Gene · 2046
Papers2,828
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,828
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Patterns of Bone Marrow Confirmed Malignant and Non-Malignant Hematological Disorders in Patients with Abnormal Hematological Parameters in Northeast Ethiopia. | J Blood Med | 2022 | 35210892 | PubTator, text mining | PubMed |
| The Antianginal Drug Perhexiline Displays Cytotoxicity against Colorectal Cancer Cells In Vitro: A Potential for Drug Repurposing. | Cancers (Basel) | 2022 | 35205791 | PubTator, text mining | PubMed |
| EPHA2, EPHA4, and EPHA7 Expression in Triple-Negative Breast Cancer. | Diagnostics (Basel) | 2022 | 35204461 | PubTator, text mining | PubMed |
| New insights on familial colorectal cancer type X syndrome. | Sci Rep | 2022 | 35181726 | PubTator, text mining | PubMed |
| Novel Aggregation-Enhanced PEC Photosensitizer Based on Electrostatic Linkage of Ionic Liquid with Protoporphyrin IX for Ultrasensitive Detection of Molt-4 Cells. | Anal Chem | 2022 | 35172575 | PubTator, text mining | PubMed |
| Prime editing efficiency and fidelity are enhanced in the absence of mismatch repair. | Nat Commun | 2022 | 35140211 | PubTator, text mining | PubMed |
| Structure-based prediction of HDAC6 substrates validated by enzymatic assay reveals determinants of promiscuity and detects new potential substrates. | Sci Rep | 2022 | 35110592 | PubTator, text mining | PubMed |
| Pharmacological targeting PIKfyve and tubulin as an effective treatment strategy for double-hit lymphoma. | Cell Death Discov | 2022 | 35091546 | PubTator, text mining | PubMed |
| Transcriptome-guided resolution of tumor microenvironment interactions in pheochromocytoma and paraganglioma subtypes. | J Endocrinol Invest | 2022 | 35088383 | PubTator, text mining | PubMed |
| Systems-level conservation of the proximal TCR signaling network of mice and humans. | J Exp Med | 2022 | 35061003 | PubTator, text mining | PubMed |
| A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease. | Elife | 2022 | 35037854 | PubTator, text mining | PubMed |
| Comprehensive analysis of prime editing outcomes in human embryonic stem cells. | Nucleic Acids Res | 2022 | 35018468 | PubTator, text mining | PubMed |
| In Vitro Anticancer Screening and Preliminary Mechanistic Study of A-Ring Substituted Anthraquinone Derivatives. | Cells | 2022 | 35011730 | PubTator, text mining | PubMed |
| The Profile of MicroRNA Expression and Potential Role in the Regulation of Drug-Resistant Genes in Cisplatin- and Paclitaxel-Resistant Ovarian Cancer Cell Lines. | Int J Mol Sci | 2022 | 35008952 | PubTator, text mining | PubMed |
| Integrated bioinformatics and network pharmacology to identify the therapeutic target and molecular mechanisms of Huangqin decoction on ulcerative Colitis. | Sci Rep | 2022 | 34997010 | PubTator, text mining | PubMed |
| Scavenger receptors in host defense: from functional aspects to mode of action. | Cell Commun Signal | 2022 | 34980167 | PubTator, text mining | PubMed |
| Precise genome editing across kingdoms of life using retron-derived DNA. | Nat Chem Biol | 2022 | 34949838 | PubTator, text mining | PubMed |
| Artesunate-induced Cellular Effects Are Mediated by Specific EPH Receptors and Ephrin Ligands in Breast Carcinoma Cells. | Cancer Genomics Proteomics | 2022 | 34949656 | PubTator, text mining | PubMed |
| Programmable deletion, replacement, integration and inversion of large DNA sequences with twin prime editing. | Nat Biotechnol | 2022 | 34887556 | PubTator, text mining | PubMed |
| KDM1A inhibition augments the efficacy of rapamycin for the treatment of endometrial cancer. | Cancer Lett | 2022 | 34673129 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2046/papers?page=19